Zum Hauptinhalt springen

Hepatitiden

11. August 2024 | Hepatitiden

Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective study.

Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective study. Ryan P, Valencia J, Cuevas G, Amigot-Sanchez R, Martínez I, Lazarus JV, Pérez-García F, Resino S. Euro Surveil...

16. Juli 2024 | Hepatitiden

Infektionen mit dem Hepatitis-C-Virus (HCV): Anteil der Personen mit chronischer HCV-Infektion und späterer Versorgung höher als erwartet

Infektionen mit dem Hepatitis-C-Virus (HCV): Anteil der Personen mit chronischer HCV-Infektion und späterer Versorgung höher als erwartet Dtsch Arztebl 2024; 121(14): A-966 / B-830 Schulze, Anne-Kristin https://www.aerzteblatt.de/archiv/240244

02. Juli 2024 | Hepatitiden

Missed Opportunities: A Retrospective Study of Hepatitis C Testing in Hospital Inpatients.

Missed Opportunities: A Retrospective Study of Hepatitis C Testing in Hospital Inpatients. Roder C, Cosgrave C, Mackie K, McNamara B, Doyle JS, Wade AJ. Viruses. 2024 Jun 18;16(6):979. doi: 10.3390/v16060979. PMID: 38932269; PMCID: P...

02. Juli 2024 | Hepatitiden

Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial.

Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial. Malme KB, Stene-Johansen K, Klundby I, Backe Ø, Foshaug T, Greve MH, Pihl CM, Finbråten AK, Da...

02. Juli 2024 | Hepatitiden

A framework for approaching hepatitis C reinfection in people who use drugs.

A framework for approaching hepatitis C reinfection in people who use drugs. Kim RG, Price JC. Clin Liver Dis (Hoboken). 2024 Jun 12;23(1):e0200. doi: 10.1097/CLD.0000000000000200. PMID: 38872769; PMCID: PMC11168836. https://www.ncb...

02. Juli 2024 | Hepatitiden

Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study.

Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study. Dickerson SS, George SJ, Ventuneac A, Dharia A, Talal AH. J Med Internet Res. 2024 Jun 12;26:e5304...

09. Juni 2024 | Hepatitiden

EASL position paper on clinical follow-up after HCV cure.

EASL position paper on clinical follow-up after HCV cure. Reiberger T, Lens S, Cabibbo G, Nahon P, Zignego AL, Deterding K, Elsharkawy AM, Forns X. J Hepatol. 2024 May 30:S0168-8278(24)00275-7. doi: 10.1016/j.jhep.2024.04.007. Epub ahead ...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten